Search Results - BC Cancer Agency Library

c.1 BC Cancer Agency VAN Library			Available
c.1 BC Cancer Agency ARHCC Library			Available
c.1 BC Cancer Agency KEL Library			Available
c.1 BC Cancer Agency VIC Library			Available
c.2 BC Cancer Agency KEL Library			Available
c.2 BC Cancer Agency VAN Library			Available

Molecular biology of cancer : mechanisms, targets, and therapeutics

https://bccalibrary.andornot.com/en/permalink/catalog16578

Pecorino, Lauren. New York, NY: Oxford University Press , 2008. 2nd ed.

Audience: Professional

Call Number: QZ200 P369m 2008

Availability: 3 copies, 3 available

Author: Pecorino, Lauren

Edition: 2nd ed.

Place of Publication: New York, NY

Publisher: Oxford University Press

Publication Date: 2008

Physical Description: xviii, 316 p. : ill. ; 25 cm.

Subjects: Neoplasms - etiology; Neoplasms - genetics; Neoplasms - therapy; Cell Transformation, Neoplastic - genetics; Antineoplastic Agents - therapeutic use; Molecular Biology

ISBN: 9780199211487; 0199211485

Language: English

Material Type: Book

Audience: Professional

Location: Vancouver Library; Surrey Library; Victoria Library; Kelowna Library

Call Number: QZ200 P369m 2008

Copies

c.1 BC Cancer Agency KEL Library			Available
c.1 BC Cancer Agency VAN Library			Available
c.1 BC Cancer Agency VIC Library			Available

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog122174

Cambridge, MA: Elsevier, Inc. , 2020.

Audience: Professional

Call Number: QZ266 C538 2020

Availability: 3 copies, 3 available

Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…

Editor: Lee, Daniel W.; Shah, Nirali N.

Place of Publication: Cambridge, MA

Publisher: Elsevier, Inc.

Publication Date: 2020

Physical Description: xiv, 229 p. : ill. ; 24 cm.

Subjects: Neoplasms - therapy; Receptors, Chimeric Antigen - therapeutic use; Receptors, Antigen, T-Cell; Immunotherapy, Adoptive - methods; Cell- and Tissue-Based Therapy

Abstract: Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.